Commercialization & Healthcare Management
Consulting Services
What we do...
Adamantine's healthcare management consulting services are designed to help organizations in the healthcare industry improve their operations and financial performance. Our team of experienced consultants has a deep understanding of the healthcare industry and is ready to help your organization reach its goals.
Areas of Focus
Revenue Enhancement & Cost Reduction
Revenue Enhancement & Cost Reduction
Revenue Enhancement & Cost Reduction
We help organizations increase their revenues through a variety of strategies, including improving vendor/partner relations and expanding into new markets. Our team also works with organizations to identify opportunities to reduce costs and improve their bottom line.
Process Improvement
Revenue Enhancement & Cost Reduction
Revenue Enhancement & Cost Reduction
We help organizations streamline their processes and identify inefficiencies that can be eliminated to save time and money. Our team will also assist organizations with the implementation of new technologies to improve efficiency and effectiveness.
Regulatory & Compliance
Revenue Enhancement & Cost Reduction
Regulatory & Compliance
We help organizations ensure that they are in compliance with all relevant regulations and standards. Whether your organization is looking to manufacturer and commercialize drugs or devices, our team of experts and partners can guide you along the way.
Areas of Expertise
Medical Device - 510(k)
The 510(k) process is a regulatory pathway for medical devices that are "substantially equivalent" to a device that is already on the market, also known as a "predicate device." In order to be cleared for sale in the United States, a 510(k) medical device must demonstrate that it is as safe and effective as the predicate device, but it is not required to undergo clinical testing.
The process for new medical devices that do not have a predicate device and are required to undergo clinical testing are required to go through the premarket approval (PMA) process.
Human Drug Commercialization
Pharmaceutical commercialization refers to the process of bringing a new drug or medication to market. This includes a wide range of activities, such as researching and developing the drug, obtaining regulatory approvals, manufacturing the drug, and marketing and distributing it to patients and healthcare providers. The ultimate goal of pharmaceutical commercialization is to make new drugs available to patients who need them, while also generating revenue for the companies that develop and sell them.
